viewNanoveu Ltd

Nanoveu in back-to-back trading halts ahead of capital raising news

The company has recently signed agreements with Sanyo Trading Company Ltd for exclusive distribution of its antiviral products.

Nanoveu Ltd - Nanoveu in trading halt ahead of a capital raising
Under the agreement Sanyo will generate orders for Nanoveu’s B2B antiviral film

Nanoveu Ltd (ASX:NVU) has been granted back-to-back trading halts by the ASX pending a capital raising announcement.

The trading halt will be in place until the announcement is made or the start of normal ASX trading on Friday, August 7, whichever occurs sooner.

Distribution agreements 

Nanoveu recently signed distribution agreements for its antiviral protection products for the Thai and Malaysian markets with Sanyo Trading Company Ltd.

Through these agreements, Sanyo will look to leverage its extensive contacts in the Asia-Pacific region to distribute several Nanoveu’s products to groups including hospitals, banks, schools and shopping malls.

Nanoveu will ship its business to business (B2B) rolls of antiviral film – to be applied to an increasing number of surfaces – in addition to its consumer-focused antiviral mobile phone cases and door handles.

The company’s antiviral technology has been independently demonstrated to be a highly effective agent for the eradication of viruses.

It has been proven to eliminate 99.99% of OC43, a viral strain affecting humans that is also a surrogate for COVID-19, in 30 minutes.

Quick facts: Nanoveu Ltd

Price: 0.066 AUD

Market: ASX
Market Cap: $10.31 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Nanoveu Ltd named herein, including the promotion by the Company of Nanoveu Ltd in any Content on the Site, the Company receives from said...


Nanoveu focused on commercialising EyeFyx product following 'revolutionary'...

Nanoveu Ltd's (ASX:NVU) Alfred Chong caught up with Proactive's Andrew Scott after completing what they describe as a revolutionary advanced prototype of its EyeFyx product. It's designed to correct farsightedness for people using digital devices without the need for glasses. The company has...

on 18/11/20

2 min read